Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (301-310 of 940) with videos related to

Pageof 94
Sort By:
Neuro-Oncology Advances|July 10, 2020
Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activityBirthe Lohmann, Manuela Silginer, Daniel Picard, et al.
Nature Reviews. Disease Primers|May 9, 2024
GliomaMichael Weller, Patrick Y Wen, Susan M Chang, et al.
Neuro-Oncology|July 30, 2022
Improved seizure control in patients with recurrent glioblastoma treated with bevacizumabCaroline Hertler, Katharina Seystahl, Emilie Le Rhun, et al.
Journal of Neuro-Oncology|June 1, 2005
Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patientsWilhelm Küker, Thomas Nägele, Agnieska Korfel, et al.
Molecular Cancer Therapeutics|April 6, 2017
Biological Role and Therapeutic Targeting of TGF-β<sub>3</sub> in GlioblastomaKatharina Seystahl, Alexandros Papachristodoulou, Isabel Burghardt, et al.
International Journal of Cancer|July 9, 2005
Supraagonistic, bispecific single-chain antibody purified from the serum of cloned, transgenic cows induces T-cell-mediated killing of glioblastoma cells in vitro and in vivoLudger Grosse-Hovest, Wolfgang Wick, Rosa Minoia, et al.
Nature Reviews. Neurology|May 13, 2017
Vaccine-based immunotherapeutic approaches to gliomas and beyondMichael Weller, Patrick Roth, Matthias Preusser, et al.
European Journal of Neurology|May 12, 2022
Venous thromboembolic events in glioblastoma patients: An epidemiological studyAmanda Eisele, Katharina Seystahl, Elisabeth J Rushing, et al.
Oncotarget|April 8, 2015
Transforming growth factor-β pathway activity in glioblastomaKarl Frei, Dorothee Gramatzki, Isabel Tritschler, et al.
Brain Pathology (Zurich, Switzerland)|October 9, 2007
A 63-year-old man with dementia, ataxia and VI nerve palsyMichel Mittelbronn, Stefan M Kröber, Annika Wersebe, et al.
Pageof 94

Showing results (301-310 of 940) with videos related to

Sort By:
Pageof 94
Neuro-Oncology Advances|July 10, 2020
Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activityBirthe Lohmann, Manuela Silginer, Daniel Picard, et al.
Nature Reviews. Disease Primers|May 9, 2024
GliomaMichael Weller, Patrick Y Wen, Susan M Chang, et al.
Neuro-Oncology|July 30, 2022
Improved seizure control in patients with recurrent glioblastoma treated with bevacizumabCaroline Hertler, Katharina Seystahl, Emilie Le Rhun, et al.
Journal of Neuro-Oncology|June 1, 2005
Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patientsWilhelm Küker, Thomas Nägele, Agnieska Korfel, et al.
Molecular Cancer Therapeutics|April 6, 2017
Biological Role and Therapeutic Targeting of TGF-β<sub>3</sub> in GlioblastomaKatharina Seystahl, Alexandros Papachristodoulou, Isabel Burghardt, et al.
International Journal of Cancer|July 9, 2005
Supraagonistic, bispecific single-chain antibody purified from the serum of cloned, transgenic cows induces T-cell-mediated killing of glioblastoma cells in vitro and in vivoLudger Grosse-Hovest, Wolfgang Wick, Rosa Minoia, et al.
Nature Reviews. Neurology|May 13, 2017
Vaccine-based immunotherapeutic approaches to gliomas and beyondMichael Weller, Patrick Roth, Matthias Preusser, et al.
European Journal of Neurology|May 12, 2022
Venous thromboembolic events in glioblastoma patients: An epidemiological studyAmanda Eisele, Katharina Seystahl, Elisabeth J Rushing, et al.
Oncotarget|April 8, 2015
Transforming growth factor-β pathway activity in glioblastomaKarl Frei, Dorothee Gramatzki, Isabel Tritschler, et al.
Brain Pathology (Zurich, Switzerland)|October 9, 2007
A 63-year-old man with dementia, ataxia and VI nerve palsyMichel Mittelbronn, Stefan M Kröber, Annika Wersebe, et al.
Pageof 94